| |
| |
|
| Insider
Information: |
Haqq Christopher |
| Relationship: |
|
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
333,924 |
|
|
Indirect Shares
|
20,000 |
|
|
| Direct
Value |
$234,622 |
|
|
|
Indirect Value
|
$13,800 |
|
|
| Total
Shares |
353,924 |
|
|
| Total
Value |
$248,422 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
EVP, R&D & Chief Scien... |
2019-02-15 |
271,943 |
2019-02-15 |
20,000 |
Premium* |
|
|
Surrozen Ord Shs |
SRZN |
Former Director |
2021-08-11 |
30,000 |
2021-08-11 |
0 |
Premium* |
|
|
Elicio Therapeutics Ord Shs |
ELTX |
|
2023-06-01 |
31,981 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELTX |
Elicio Therapeutics Ord S... |
See Remarks |
• – – |
2023-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
31,981 |
|
- |
|
| SRZN |
Surrozen Ord Shs |
Former Director |
– – – |
2021-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2019-02-15 |
4 |
AS |
$39.59 |
$30,682 |
D/D |
(775) |
271,943 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2019-02-11 |
4 |
AS |
$38.55 |
$538,736 |
D/D |
(13,975) |
272,718 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
286,693 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2019-02-06 |
4 |
D |
$38.47 |
$58,167 |
D/D |
(1,512) |
271,693 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2019-02-06 |
4 |
AS |
$38.04 |
$477,922 |
D/D |
(12,375) |
273,205 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2018-09-26 |
4 |
AS |
$43.08 |
$581,580 |
D/D |
(13,500) |
286,355 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2018-09-25 |
4 |
AS |
$40.26 |
$546,905 |
D/D |
(13,500) |
299,855 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2018-09-24 |
4 |
AS |
$39.74 |
$718,425 |
D/D |
(18,000) |
313,355 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2018-08-15 |
4 |
AS |
$37.54 |
$29,094 |
D/D |
(775) |
331,355 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2018-05-15 |
4 |
AS |
$44.44 |
$1,167,480 |
D/D |
(25,775) |
332,130 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2018-05-15 |
4 |
OE |
$11.00 |
$275,000 |
D/D |
25,000 |
357,905 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2018-03-26 |
4 |
AS |
$39.76 |
$729,265 |
D/D |
(18,327) |
332,905 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
553 |
351,232 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2018-02-09 |
4 |
D |
$41.70 |
$205,373 |
D/D |
(4,925) |
350,679 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2018-02-06 |
4 |
D |
$35.80 |
$158,451 |
D/D |
(4,426) |
355,604 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
360,030 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2017-11-15 |
4 |
AS |
$13.36 |
$21,429 |
D/D |
(1,604) |
342,530 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2017-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
829 |
344,134 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2017-10-16 |
4 |
AS |
$14.35 |
$86,100 |
D/D |
(6,000) |
343,305 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2017-09-15 |
4 |
AS |
$15.30 |
$91,800 |
D/D |
(6,000) |
349,305 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2017-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
829 |
362,909 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2017-08-15 |
4 |
AS |
$14.75 |
$112,159 |
D/D |
(7,604) |
355,305 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2017-07-17 |
4 |
AS |
$14.92 |
$89,520 |
D/D |
(6,000) |
362,080 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
